| R10302 |
CO1686 Intermediate1 |
Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit
|
| R10303 |
CO1686 Intermediate2 |
Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit
|
| R10304 |
CO1686 Intermediate3 |
Rociletinib (CO-1686, AVL-301) is an irreversible, mutant-selective EGFR inhibit
|
| R10305 |
HKI272; HKI272; Neratinib Intermediate1 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10306 |
HKI272; HKI272; Neratinib Intermediate2 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10307 |
HKI272; HKI272; Neratinib Intermediate3 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10308 |
HKI272; HKI272; Neratinib Intermediate4 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10309 |
E7080; E7080; Lenvatinib Intermediate1 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10310 |
E7080; E7080; Lenvatinib Intermediate2 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10311 |
E7080; E7080; Lenvatinib Intermediate3 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10312 |
E7080; E7080; Lenvatinib Intermediate4 |
Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 5
|
| R10315 |
PD0332991; Palbociclib Intermediate1 |
Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi
|
| R10316 |
PD0332991; Palbociclib Intermediate2 |
Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi
|
| R10317 |
PD0332991; Palbociclib Intermediate3 |
Palbociclib (PD0332991) Isethionate is a highly selective inhibitor of CDK4/6 wi
|
| R10318 |
Valsartan/sacubitril; LCZ696 Intermediate1 |
LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally
|
| R10319 |
Valsartan/sacubitril; LCZ696 Intermediate2 |
LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally
|
| R10320 |
Valsartan/sacubitril; LCZ696 Intermediate3 |
LCZ696, consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally
|
| R10387 |
Allantoin |
CAS NO.:97-59-6Product Name:1-(2,5-Dioxoimidazolidin-4-yl)ureaSynonyms:(2,5-diox
|
| R10388 |
Repaglinide |
CAS NO.:135062-02-1Product Name:(S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-y
|
| R10389 |
Metformin hydrochloride |
CAS NO.:1115-70-4Product Name:Metformin HCLSynonyms:Metformin Hydrochloride; 3-(
|
| R10390 |
Phenformin Hydrochloride |
CAS NO.:834-28-6Product Name:phenformin hydrochlorideSynonyms:PHENFORMIN HCL; Ph
|
| R10391 |
Pioglitazone Hydrochloride |
|
| R10392 |
Glibenclamide; Glyburide |
|
| R10393 |
Glimepiride |
|
| R10394 |
Rosiglitazone Hydrochloride |
CAS NO.:302543-62-0Product Name:5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl
|